Company & Sponsor Intelligence
University of Manchester
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed3
Countries1
Therapeutic footprint
adhddepressionother_neurologyout_of_scope
Indexed studies
NCT05956912Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
depression · United KingdomUNKNOWN
depression · United KingdomUNKNOWN
NCT03853382Cognitive Analytic Therapy-informed Containment for Self-Harm (CATCH)
out_of_scope · United KingdomNA
out_of_scope · United KingdomNA
NCT03310996Non-invasive Stimulation in Neurofibromatosis Type 1
other_neurology · United KingdomNA
other_neurology · United KingdomNA
NCT02516917The Feasibility of a Brief Attention Training Technique in Improving Behaviour and Attention in Children With ADHD
adhd · United KingdomNA
adhd · United KingdomNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →